A Study of Intra-Dermal Injection of Botulinum Toxin Type A for the Diabetic Neuropathic Foot Pain
Phase of Trial: Phase II
Latest Information Update: 25 Jul 2011
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Therapeutic Use
- 25 Jul 2011 Actual end date (December 2007) added as reported by ClinicalTrials.gov.
- 25 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Oct 2006 New trial record.